Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $73.2300 (1.78%) ($70.9600 - $74.5800) on Fri. Apr. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.9% (three month average) | RSI | 61 | Latest Price | $73.2300(1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.8% a day on average for past five trading days. | Weekly Trend | LGND declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) XBI(52%) IWC(49%) IWM(49%) | Factors Impacting LGND price | LGND will decline at least -2.95% in a week (0% probabilities). VIXM(-28%) VXX(-17%) UUP(-16%) TLT(-3%) UNG(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.95% (StdDev 5.9%) | Hourly BBV | 0 () | Intraday Trend | 1.9% | | | |
|
Resistance Level | $76.17 | 5 Day Moving Average | $71.48(2.45%) | 10 Day Moving Average | $71.18(2.88%) | 20 Day Moving Average | $76.17(-3.86%) | To recent high | -32.1% | To recent low | 15.6% | Market Cap | $1.177b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |